Two distinct major facilitator superfamily drug efflux pumps mediate chloramphenicol resistance in Streptomyces coelicolor

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 11, 2009, Pages 4673-4677

  Vecchione, James J ^a   Alexander Jr , Blair ^b   Sello, Jason K ^a  

^a BROWN UNIVERSITY   (United States)

^b MOREHOUSE COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 NAPHTHYLAMINE; CHLORAMPHENICOL; FLORFENICOL; PHENYLALANYLARGINYL BETA NAPHTHYLAMIDE; RESERPINE; THIAMPHENICOL; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; CMIR1 GENE; CMIR2 GENE; CONTROLLED STUDY; DRUG POTENCY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOMYCES COELICOLOR;

BACTERIAL PROTEINS; CHLORAMPHENICOL RESISTANCE; DIPEPTIDES; RESERPINE; STREPTOMYCES COELICOLOR;

EID: 70350328014     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00853-09     Document Type: Article

References (34)

1. Bentley, S. D., K. F. Chater, A. M. Cerdeño-Tarraga, G. L. Challis, N. R. Thomson, K. D. James, et al. 2002. Complete genome sequence of the model actinomycete Streptomyces coelicolor. Nature 417:141-147.
2. Bina, X. R., J. A. Philippart, and J. E. Bina. 2009. Effect of the efflux inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β- naphthylamide on antimicrobial susceptibility and virulence factor production in Vibrio cholerae. J. Antimicrob. Chemother. 63:103-108.
3. Blanc, V., K. Salah-Bey, M. Flotcher, and C. J. Thompson. 1998. Molecular characterization and transcriptional analysis of a multidrug resistance gene cloned from pristinamycin-producing organism, Streptomyces pristinaespiralis. Mol. Microbiol. 17:989-999.
4. Bohn, C., and P. Bouloc. 1998. The Escherichia coli cmlA gene encodes the multidrug efflux pump Cmr/MdfA and is responsible for isopropyl-beta-D- thiogalactopyranoside exclusion and spectinomycin sensitivity. J. Bacteriol. 180:6072-6075.
5. Braibant, M., J. Chevalier, E. Chaslus-Dancla, J.-M. Pagès, and A. Cloeckaert. 2005. Structural and functional study of the phenicol-specific efflux pump FloR belonging to the major facilitator superfamily. Antimicrob. Agents Chemother. 49:2965-2971.
6. Brenwald, N., M. Gill, and R. Wise. 1997. The effect of reserpine, an inhibitor of multi-drug efflux pumps, on the in-vitro susceptibilities of fluoroquinolone- resistant strains of Streptococcus pneumoniae to norfloxacin. J. Antimicrob. Chemother. 40:458-460.
7. Camus, J. C., M. J. Pryor, C. Medigue, and S. T. Cole. 2002. Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv. Microbiology 148:2967-2973.
8. Danilchanka, O., C. Mailaender, and M. Niederweis. 2008. Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 52:2503-2511.
9. D'Costa, V. M., K. M. McGrann, D. W. Hughes, and G. D. Wright. 2006. Sampling the antibiotic resistome. Science 311:374-377.
10. Dittrich, W., M. Betzler, and H. Schrempf. 1991. An amplifiable and deletable chloramphenicol-resistance determinant of Streptomyces lividans 1326 encodes a putative transmembrane protein. Mol. Microbiol. 5:2789-2797.
11. Fernández-Moreno, M. A., L. Carbó, T. Cuesta, C. Vallín, and F. Malpartida. 1998. A silent ABC transporter isolated from Streptomyces rochei F20 induces multidrug resistance. J. Bacteriol. 180:4017-4023.
12. Gregory, M. A., R. Till, and M. C. M. Smith. 2003. Integration site for Streptomyces phage ΦBT1 and development of site-specific integrating vectors. J. Bacteriol. 185:5320-5323.
13. Gust, B., G. L. Challis, K. Fowler, T. Kieser, and K. F. Chater. 2003. PCR-targeted Streptomyces gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin. Proc. Natl. Acad. Sci. USA 100:1541-1546.
14. Hong, H. J., M. I. Hutchings, L. M. Hill, and M. J. Buttner. 2005. The role of the novel Fem protein VanK in vancomycin resistance in Streptomyces coelicolor. J. Biol. Chem. 280:13055-13061.
15. Jones, G. H., M. S. B. Paget, L. Chamberlin, and M. J. Buttner. 1997. Sigma-E is required for the production of the antibiotic actinomycin in Streptomyces antibioticus. Mol. Microbiol. 23:169-178.
16. Kieser, T., M. J. Bibb, M. J. Buttner, K. F. Chater, and D. A. Hopwood. 2000. Practical Streptomyces genetics. John Innes Foundation, Norwich, United Kingdom.
17. Lee, L.-F., and C. W. Chen. 1998. Multidrug resistant genes in Streptomyces. Actinomycetology 12:148-152.
18. Llanes, C., D. Hocquet, C. Vogne, D. Benali-Baitich, C. Neuwirth, and P. Plésiat. 2004. Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously. Antimicrob. Agents Chemother. 48:1797-1802.
19. Lomovskaya, O., M. S. Warren, A. Lee, J. Galazzo, R. Fronko, M. Lee, et al. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105-116.
20. Lomovskaya, O., and K. A. Bostian. 2006. Practical applications of efflux pump inhibitors in the clinic - a vision for applied use. Biochem. Pharmacol. 71:910-918.
21. Lomovskaya, O., H. I. Zgurskaya, M. Totrov, and W. J. Watkins. 2007. Waltzing transporters and 'the dance macabre' between humans and bacteria. Nat. Rev. Drug Discov. 6:56-65.
22. Mahamoud, A., J. Chevalier, S. Alibert-Franco, W. V. Kern, and J.-M. Pagés. 2007. Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy. J. Antimicrob. Chemother. 59:1223-1229.
23. Martinez, J. L. 2008. Antibiotics and antibiotic resistance genes in natural environments. Science 321:365-367. (Pubitemid 352029941)
24. Neyfakh, A. A. 1992. The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein. Antimicrob. Agents Chemother. 36:484-485.
25. Pannek, S., P. G. Higgins, P. Steinke, D. Jonas, M. Akova, J. A. Bohnert, H. Seifert, and W. V. Kern. 2006. Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-β-naphthylamide. J. Antimicrob. Chemother. 57:970-974.
26. Poole, K., and O. Lomovskaya. 2006. Can efflux inhibitors really counter resistance? Drug Discov. Today Ther. Strat. 3:145-152.
27. Renau, T. E., R. Léger, E. M. Flamme, J. Sangalang, M. W. She, R. Yen, et al. 1999. Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. J. Med. Chem. 42:4928-4931.
28. Sáenz, Y., J. Ruiz, M. Zarazaga, M. Teixidó, C. Torres, and J. Vila. 2003. Effect of the efflux pump inhibitor Phe-Arg-β-naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin. J. Antimicrob. Chemother. 53:544-545.
29. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
30. Schmitz, F., A. Fluit, M. Luckefahr, B. Engler, B. Hofmann, J. Verhoef, H. Heinz, U. Hadding, and M. Jones. 1998. The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. J. Antimicrob. Chemother. 42:807-810. (Pubitemid 29008084)
31. Tahlan, K., S. K. Ahn, A. Sing, T. D. Bodnaruk, A. R. Willems, A. R. Davidson, and J. R. Nodwell. 2007. Initiation of actinorhodin export in Streptomyces coelicolor. Mol. Microbiol. 63:951-961.
32. Vecchione, J. J., and J. K. Sello. 2008. Characterization of an inducible, antibiotic-resistant aminoacyl-tRNA synthetase gene in Streptomyces coelicolor. J. Bacteriol. 190:6253-6257.
33. Webber, M. A., and L. V. J. Piddock. 2003. The importance of efflux pumps in bacterial antibiotic resistance. J. Antimicrob. Chemother. 51:9-11.
34. Ziha-Zarifi, I., C. Llanes, T. Köhler, J.-C. Pechére, and P. Plésiat. 1999. In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM. Antimicrob. Agents Chemother. 43:287-291.